We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
The illumigene molecular amplification assay detects the presence of the toxin producing region from the C difficile DNA, and provides accurate results in under an hour. Meridian claims
Onko-Sure is a simple, non-invasive, patent-pending and regulatory-approved in-vitro diagnostic test for the monitoring of colorectal cancer and for lung cancer detection and treatment monitoring by measuring the
Intercept is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in
In his position, Elam will drive customer satisfaction and continue to expand Capitol’s involvement in local, national and international markets. Before joining Capitol Scientific, Elam worked as a
VaxDesign is the developer of the Modular IMmune In-vitro Construct (MIMIC) technology that melds immunology with engineering to find solutions to complex biological problems. MIMIC will be relevant
Prior to joining Aethlon, Frakes served as the chief financial officer for four public companies over a period of 16 years. Aethlon chief executive officer James Joyce said
With the support of grants from the Alberta Livestock and Meat Agency and Genome Canada, Chronix is working in partnership with the University of Calgary to develop a
The merger brings $42m in assets to Biomagnetics, including land to expand, when necessary, to meet future production levels to fill anticipated market demands. Biomagnetics president Clayton Hardman
The trial will evaluate the value of genetic testing on reducing adverse events associated with Warfarin therapy. GenMark, a provider of automated, multiplex molecular diagnostic testing systems, said
According to Progenika Biopharma, the diagnostic test rapidly diagnoses patients with complete and partial lipoprotein lipase deficiency (LPLD) and has been developed under an agreement with Amsterdam Molecular